Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Pilot Study to Evaluate the Anti-Tumor Effect of Durvalumab (Medi4736) in Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN), Human Papilloma Virus (HPV) Positive Versus Negative, When Treated Before Surgery

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02827838
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:44.783340+00:00
Published At
2025-03-17T00:00:00+00:00
Record Updated At
2025-03-17
Results Posted At
2025-03-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Human Papillomavirus Infection", "Stage I Oral Cavity Squamous Cell Carcinoma", "Stage I Oropharyngeal Squamous Cell Carcinoma", "Stage II Oral Cavity Squamous Cell Carcinoma", "Stage II Oropharyngeal Squamous Cell Carcinoma", "Stage III Oral Cavity Squamous Cell Carcinoma", "Stage III Oropharyngeal Squamous Cell Carcinoma", "Stage IVA Oral Cavity Squamous Cell Carcinoma", "Stage IVA Oropharyngeal Squamous Cell Carcinoma", "Stage IVB Oral Cavity Squamous Cell Carcinoma", "Stage IVB Oropharyngeal Squamous Cell Carcinoma", "Stage IVC Oropharyngeal Squamous Cell Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-17"
protocolSection.identificationModule.nctId
"NCT02827838"
protocolSection.identificationModule.officialTitle
"Pilot Study to Evaluate the Anti-Tumor Effect of Durvalumab (Medi4736) in Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN), Human Papilloma Virus (HPV) Positive Versus Negative, When Treated Before Surgery"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-03-17"

Study condition terms

  • Human Papillomavirus Infection (protocolSection.conditionsModule.conditions)
  • Stage I Oral Cavity Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage II Oral Cavity Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage II Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Oral Cavity Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Oral Cavity Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVB Oral Cavity Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVB Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVC Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.